Abstract:Objective To research the prevalence of the occult hepatitis B virus infection (OBI) among the natural population in Changsha from 2018 to 2021 and to explore the genotype distribution of virus strain and the mutation of amino acid sequence in S region , so as to provide an epidemiological and molecular biological basis for exploring the prevention and control of OBI in this region. Methods A total of 68, 513 serum samples from september 2018 to december 2021 were collected, Among them, OBI samples were screened, yield and their epidemiological characteristics were analyzed. Confirmed OBI samples will be tested for serology and high-susceptibility viral load testing, and were genetically amplified in the S region by nested PCR amplification and sequenced, HBV gentyping and amino acid mutation analysis in the S-region were performed using MEGA6.0 software. Results 27 OBI samples were confirmed , the detection rate of OBI was 0.039%; 5 OBI serological patterns were found, anti-HBc positive rate was 88.90% in all samples; HBV DNA nucleic acid quantitative ranged from 9.0 to 191.0(IU/mL) (median value of 19.0); 8 samples of those OBI donors were amplified for S region, all those are B genotype, which was shown amino acid mutation in MHR region of S gene, especially in HBV“a”epitope. Conclusion The OBI rate of natural population in Changsha is at low level in china (0.0106%-2.71%) from 2018 to 2021; The genotype of HBV is mainly type B, The mutation in MHR region of S gene, especially in HBV “a”epitope may be one of the important factors to cause OBI.
王远懿, 张毕明, 候正利, 杨茜, 阙正书. 2018—2021年长沙地区自然人群隐匿性乙型肝炎病毒感染状况及S区变异分析[J]. 湖南师范大学学报(医学版), 2023, 20(4): 60-64.
WANG Yuanyi, ZHANG Biming, HOU Zhengli, YANG Qian, QUE Zhengshu. Infection situation and S gene mutation of occult hepatitis B virus infection among natural population in Changsha from 2018 to 2021. HuNan ShiFan DaXue XueBao(YiXueBan), 2023, 20(4): 60-64.
[1] Stasi C, Silvestri C, Voller F.Hepatitis B vaccination immunotherapies: an update[J]. Clin Exp Vaccine Res, 2020, 9(1): 1-7. [2] Raimondo G, Locamini S, Pollicino T, et al.Update of the statements on biology an clinical impact of occult hepatitis B virus infection[J]. J Hepatol, 2019, 71(2): 397-408. [3] 鲁凤民, 廖昊, 刘永振, 等. 隐匿性乙型肝炎病毒感染再认识[J]. 中华预防医学杂志, 2019, 53(5): 445-449. [4] 蒋菲菲, 吕蓉, 李敏, 等. 华东地区献血者人群隐匿性乙型肝炎病毒感染及S 区变异分析[J]中国输血杂志, 2017, 30(7): 762-766. [5] 何水珍, 苏成豪, 沈理通, 等. 厦门市自然人群中乙型肝炎病毒隐匿性感染状况调查[J]. 中华预防医学杂志, 2015, 49(2): 132-136. [6] 左晓娇, 姚晓琴, 杨华, 等. 四川地区自然人群中隐匿性乙型肝炎病毒感染状况及病毒学特征[J]. 中华医院感染学杂志, 2022, 32(13): 1921-1925 [7] 孙妮, 谢毓滨, 张会平, 等. 长沙地区无偿献血人群隐匿性乙型肝炎病毒感染情况分析[J] 实用预防医学, 2022, 59(5): 560-563. [8] Mark LY, Wong DK, Pollicino T, et al.Occult hepatitis B infection and hepatocellular carcinoma: epidemiology, virology, hepatocarcinogenesis and clinical significance[J]. J Hepatol, 2020, 73(4): 952-964. [9] 李凤园, 潘彤. 献血者隐匿性乙型肝炎感染的研究进展[J]. 齐齐哈尔医学院学报, 2023, 44(11): 1064-1070. [10] 叶贤林, 李懿, 李彤, 等. 计划免疫前后出生的献血者 HBV DNA 阳性状况及其HBV 感染的血清学和分子病毒学特征分析[J] . 中国输血杂志, 2017, 30(10): 1138-1142. [11] 刘丽华, 叶贤林, 程丽娜, 等. 广东省河源地区献血人群隐匿性乙型肝炎病毒感染的血清学及分子生物学特征分析[J]. 现代检验医学杂志, 2020, 35(4): 32-36. [12] 叶贤林, 李彤, 孙淑君, 等. 核心抗体阳性合格献血者隐匿性乙肝病毒感染分子生物学特性及追踪结果的研究[J]. 中国输血杂志, 2016, 29(9): 890-894. [13] 王荣明, 江建宁. 隐匿性乙型肝炎病毒感染的生物学及临床影响的研究进展[J]. 肝脏, 2020, 25(2): 104-107. [14] Miletec M, Bingulac-Popovic J, Stojic Vidovic M, et al.Anti-HBc prevalence among croatian blood donor in a 14- year period (2004-2017): assessment of trends, risks and for implementing routing testing[J]. Transfus Clin Biol, 2019, 26(4): 257-262. [15] Varaklioti A, Kouramba A, Ioannidou P, et al.Occult hepatitis B virus infection in Greek patients with congenitial bleeding disorders[J]. Infection Genet Evol, 2017, 54(10): 397-401. [16] 徐国萍, 李倩, 戴玉柱, 等. 乙型肝炎病毒感染者持续低水平表达表面抗原S基因的序列分析[J]. 中华传染病杂志, 2019, 37(5): 280-286. [17] 莫艳萍, 施旭斌, 费静娴, 等. 湖州地区献血人群隐匿性乙型肝炎病毒感染者S基因突变分析[J]. 中国输血杂志, 2022, 35(3): 288-291. [18] 张凯, 徐东平, 陈容娟, 等. 临床大样本肝病患者隐匿性HBV感染检出情况及其HBV S基因免疫逃逸突变特点分析[J]. 解放军医学杂志, 2018, 43(5): 380-385. [19] Huang CH, Yuan Q, Chen PJ, et al.Influence of mutations in hepatitis B virtus surface protein On viral antigenicity and phenotype in occult HBV strains from blood donors[J]. J Hepatol, 2012, 57(4): 720-729. [20] Liao H, Liu Y, Chen J, et al.Characterization of hepatitis B virus (HBV) Pre S/S gene mutations in blood donors with occult HBV infection in the BaoJi area of North China[J]. Transfusion, 2017, 57(2): 857-866. [21] Ito K, Qin Y, Guarnieri M, et al.Impairment of hepatitis virus virion secretion by single- amino-acid substitutions in the small envelope protein and rescue by a novel glycosylation site[J]. Virol, 2010, 84(24): 12850-12861. [22] Yu DM, Li XH, Mom V, et al.N-glycosylation mutations within hepatitis B surface major hydrophilic region contribute mostly to immune escape[J]. J Hepatol, 2014, 60(3): 515-522. [23] 王淏. 广州献血人群隐匿性乙肝病毒感染者乙肝病毒S基因分子生物学特性及其对乙肝表面抗原表达的影响[D]. 广州: 南方医科大学, 2020. [24] Bi X, Tong S.Impcat Of immune escape mutation and N-linked glycosylation on the secretion of hepatitis B virtus virions and subviral particles: Role of the small envelope protein[J]. Virology, 2018, 518: 358-368.